Published in Hepatogastroenterology on May 29, 2001
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) (2013) 1.08
Angiography for diagnosis and treatment of colorectal cancer. World J Gastroenterol (2003) 0.84
Boron neutron capture therapy (BNCT) for liver metastasis: therapeutic efficacy in an experimental model. Radiat Environ Biophys (2012) 0.83
Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine. J Cancer Res Clin Oncol (2005) 0.81
Boron neutron capture therapy (BNCT) for liver metastasis in an experimental model: dose–response at five-week follow-up based on retrospective dose assessment in individual rats. Radiat Environ Biophys (2013) 0.79
Local platelet trapping as the cause of thrombocytopenia after hepatic cryotherapy. World J Surg (2005) 0.77
Colorectal hepatic metastasis: Evolving therapies. World J Hepatol (2014) 0.77
Superiority of combined chemo-embolization and portal infusion with 5-fluorouracil over locoregional infusion concepts in Novikoff hepatoma-bearing rats. J Cancer Res Clin Oncol (2003) 0.76
Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats. Dig Dis Sci (2004) 0.75
The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell (1999) 3.24
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). Ann Oncol (2003) 1.52
Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer. Ann Surg Oncol (1999) 1.47
Video-assisted thoracic surgery (VATS) of the lung: analysis of intraoperative and postoperative complications over 15 years and review of the literature. Surg Endosc (2007) 1.47
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. J Clin Oncol (2001) 1.20
Hyperthermia and hypoxia: new developments in anticancer chemotherapy. Eur J Surg Oncol (2001) 1.18
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma. Br J Cancer (2013) 1.15
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial. Ann Oncol (2010) 1.10
Incidence and risk factors for trocar site hernia following laparoscopic cholecystectomy: a long-term follow-up study. Hernia (2012) 1.02
Lhermitte's sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient. Eur J Neurol (2003) 0.95
Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer. J Clin Pharmacol (1998) 0.95
[Primary non-Hodgkin's lymphoma of the bone. Description of 2 cases]. Recenti Prog Med (1995) 0.94
Circulating tumor cells in metastatic inflammatory breast cancer. Ann Oncol (2009) 0.93
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori (2001) 0.93
Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients. Br J Cancer (2009) 0.93
[Liver abscess secondary to ingestion of foreign body. A case report]. G Chir (2000) 0.92
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma. Cancer Chemother Pharmacol (2008) 0.91
Role of biological markers in the clinical outcome of colon cancer. Br J Cancer (2002) 0.90
Breast metastasis from gastric signet ring cell carcinoma, mimicking inflammatory carcinoma. A case report. Tumori (1993) 0.89
Intraoperative radiotherapy: current thinking. Eur J Surg Oncol (2002) 0.88
[A case of extrarenal angiomyolipoma with intestinal localization]. Minerva Chir (1992) 0.87
Benign granular cell tumor of the breast: a misleading disease. Tumori (1999) 0.87
First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party. Bone Marrow Transplant (2004) 0.87
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. Eur J Surg Oncol (2001) 0.86
[Retractile mesenteritis: case report]. G Chir (2009) 0.85
Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer. Lung Cancer (1999) 0.84
Chagasic IgG binds and interacts with cardiac beta adrenoceptor-coupled adenylate cyclase system. Int J Immunopharmacol (1986) 0.84
Multiple gastric lipomas: report of an asymptomatic case found at autopsy. Pathol Int (1997) 0.84
A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization. Bone Marrow Transplant (2006) 0.84
Treatment of primary or metastatic pleural effusion with intracavitary cytosine arabinoside and cisplatin. A phase II study. Acta Oncol (1994) 0.84
Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery. Tech Coloproctol (2008) 0.83
[Adjuvant concomitant chemotherapy in pancreatic cancer]. Tumori (1999) 0.83
[Gastric carcinoma: a histopathological study of 705 cases]. Ann Ital Chir (1998) 0.83
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women. Breast Cancer Res Treat (2001) 0.83
Peritoneal carcinomatosis: feature of dissemination. A review. Tumori (1999) 0.83
Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's Lymphoma? Leuk Lymphoma (2000) 0.83
Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. Ann Oncol (2002) 0.82
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? Neurooncol Pract (2014) 0.82
Radiofrequency ablation of liver malignancies: MRI for evaluation of response. J Chemother (2004) 0.82
High-dose chemotherapy for triple negative breast cancer. Ann Oncol (2006) 0.82
Metastases to the submaxillary gland from breast cancer: case report. Tumori (1987) 0.82
Intra-arterial chemotherapy for unresectable pancreatic cancer. Ann Oncol (2000) 0.82
Operative cholangiography during laparoscopic cholecystectomy: considerations about routine or selective policy. G Chir (2005) 0.81
Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer. Arch Surg (2001) 0.81
Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study. Hepatogastroenterology (2001) 0.81
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial. J Exp Clin Cancer Res (2003) 0.81
Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer. Clin Oncol (R Coll Radiol) (2007) 0.81
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer. Br J Cancer (2001) 0.81
Treatment of pelvic osteosarcoma. Ann Oncol (1992) 0.81
Is there a new drug beyond floxuridine for intra-arterial hepatic chemotherapy in liver metastases from colorectal cancer? J Clin Oncol (2005) 0.81
Mitoxantrone (M) and vinblastine (V) in the treatment of advanced breast cancer. Tumori (1990) 0.80
Modulation of vascular endothelium by imatinib: a study on the EA.hy 926 endothelial cell line. J Chemother (2006) 0.80
A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study. Anticancer Res (2000) 0.80
Gastric juice nitrite and bacteria in gastroduodenal disease and resected stomach. Tumori (1983) 0.80
Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial. Eur J Surg Oncol (2006) 0.80
Chronic atrophic gastritis and risk of N-nitroso compounds carcinogenesis. Langenbecks Arch Chir (1988) 0.80
Is high-dose chemotherapy based on carboplatin, a late dose-intensification of a cisplatin-based salvage chemotherapy in germ cell tumour patients? Ann Oncol (2005) 0.80
The microflora of the gastric juice after Billroth I and Billroth II partial gastrectomy. Scand J Gastroenterol (1986) 0.80
Video-assisted thoracic surgery (VATS) lobectomy for typical bronchopulmonary carcinoid tumors. Surg Endosc (2000) 0.80
Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol (2000) 0.80
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999. Bone Marrow Transplant (2003) 0.79
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers. Ann Oncol (2000) 0.79
Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5. Nucl Med Commun (1988) 0.79
[Micromolecular multiple myeloma in the testis and subcutaneous tissue]. Recenti Prog Med (1989) 0.79
Onycholysis secondary to multiple paclitaxel 1-hour infusions: possible role for its vehicle (Cremophor EL). Ann Oncol (2003) 0.79
Thoracic stop-flow perfusion in the treatment of refractory non small cell lung cancer. J Chemother (2004) 0.78
D1 versus D2 dissection for gastric cancer. Lancet (1995) 0.78
Evaluation of carcinoembryonic antigen levels in gastric juice, stomach mucosa and plasma in high-risk and gastric cancer patients. Oncology (1986) 0.78
Intact Prototype Formation but Impaired Generalization in Autism. Res Autism Spectr Disord (2012) 0.78
Long-term results of video-assisted thoracic surgery lobectomy for stage I non-small cell lung cancer: a single-centre study of 104 cases. Interact Cardiovasc Thorac Surg (2004) 0.78
Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study. Haematologica (2001) 0.78
Retractile mesenteritis involving the colon. Eur J Surg (1994) 0.78
Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: need of guidelines for catheter positioning, port management, and anti-coagulant therapy. Ann Oncol (2001) 0.78